Editorial
Published on 17 Jan 2024
Editorial: Non-cutaneous melanoma: new therapeutic insights
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1362238
- 2,284 views
- 2 citations
- Frontiers in Oncology
- Skin Cancer
- Articles
Type at least 3 characters
343 articles
Original Research
Published on 04 Jan 2024
Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1298296
- 3,548 views
- 4 citations
Case Report
Published on 19 Dec 2023
Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1268693
- 1,764 views
- 1 citation
Brief Research Report
Published on 19 Dec 2023
Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1280730
- 2,178 views
- 6 citations
Brief Research Report
Published on 04 Dec 2023
Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1241917
- 9,577 views
Original Research
Published on 30 Nov 2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1256800
- 2,147 views
Case Report
Published on 24 Nov 2023
Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1303141
- 2,254 views
- 3 citations
Original Research
Published on 08 Nov 2023
Cost items in melanoma patients by clinical characteristics and time from diagnosis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1234931
- 1,803 views
- 1 citation
Original Research
Published on 30 Oct 2023
A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1200387
- 3,231 views
Case Report
Published on 27 Oct 2023
Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1265479
- 6,397 views
- 1 citation
Original Research
Published on 25 Oct 2023
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1282823
- 2,419 views
- 4 citations
Original Research
Published on 23 Oct 2023
Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase)
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1250026
- 2,121 views
- 5 citations
Systematic Review
Published on 13 Oct 2023
Mapping the landscape of artificial intelligence in skin cancer research: a bibliometric analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1222426
- 4,501 views
- 5 citations
Brief Research Report
Published on 05 Oct 2023
The utility of high-frequency 18 MHz ultrasonography for preoperative evaluation of acral melanoma thickness in Chinese patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1185389
- 2,236 views
- 1 citation
Editorial
Published on 28 Sep 2023
Editorial: The role of immunotherapy in melanomas
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1293040
- 1,350 views
- 1 citation
Case Report
Published on 20 Sep 2023
Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1276729
- 1,971 views
- 2 citations